Status:
UNKNOWN
Acromegaly - Before and After Treatment
Lead Sponsor:
University of Aarhus
Conditions:
Acromegaly
Growth Hormone Treatment
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to investigate sleep apnea, circulation and metabolism in acromegaly before and after surgery and/or medical treatment.
Detailed Description
Acromegaly is a rare disease caused by a growth hormone (GH) producing pituitary adenoma. Surgery is primary treatment, whereas medical treatment with a somatostatin analogue (SA), which suppresses GH...
Eligibility Criteria
Inclusion
- Recently diagnosed with acromegaly
- Age above 18
- Written consent
Exclusion
- \- Pregnancy
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03431727
Start Date
October 1 2017
End Date
December 1 2022
Last Update
December 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Department of internal medicine and endocrinologi
Aarhus, Denmark, 8000